** Shares of health insurer Elevance Health ELV.N fall 3% to $310 premarket

**  Co says the Centers for Medicare & Medicaid Services $(CMS)$ plans to halt new Medicare Advantage‑Prescription Drug enrollments from March 31 over concerns tied to how it submitted risk‑adjustment data before April 2023

** ELV says current members will not see changes to coverage and that it revised its practices last April; adds it is working with CMS but timing and outcome remain uncertain

** Shares fell 5% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))